Asthma management in 2026 – What’s changed and what matters in practice – (Clinical lunch chat on-demand)

Learning Outcomes

Following this activity, participants should be able to:

• Identify important changes introduced in the 2026 GINA recommendations and their relevance to primary care
• Explain the role of inhaled corticosteroid-containing treatment and anti inflammatory reliever strategies in reducing exacerbation risk
• Select appropriate reliever and maintenance treatment according to asthma severity, symptom control and individual patient needs
• Assess poor asthma control and identify modifiable factors before escalating treatment
• Recognise and manage acute asthma exacerbations appropriately, including indications for urgent referral
• Identify patients with difficult-to-treat or severe asthma who require further.